Aurora Cannabis Inc (ACB.TO) faced a significant drop of 5.38% in the last trading session, closing at CA$3.87.
In the latest trading session, Aurora Cannabis Inc saw its stock price fall sharply, reflecting ongoing concerns in the cannabis market. Despite reporting record revenues and positive growth metrics, the stock's performance suggests deeper issues at play.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$227.95M
52W high
$9.33
52W low
$3.59
1W change
-3.42%
Beta
1.35
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 59.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.84
+59.1% Upside
Current Price
C$3.67
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
37.1%
Annualized
90-Day Vol
48.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.07
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.46 | C$3.04 โ C$3.93 |
| 60 trading days | C$3.26 | C$2.72 โ C$3.90 |
| 90 trading days | C$3.07 | C$2.46 โ C$3.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Aurora Cannabis's financial health and market conditions, especially given its recent stock decline despite positive revenue reports.
Bull case
Aurora Cannabis has shown impressive annual revenue growth, indicating strong demand for its products. This growth could lead to a recovery in stock price as the company continues to capitalize on market opportunities.
Bear case
The recent decline in stock raises concerns about Aurora's ability to maintain profitability in a competitive market, especially since it continues to operate at a loss. Investors may need to reassess their expectations regarding the company's financial stability.
Recent Performance Overview
On the last trading day, Aurora Cannabis Inc's stock dropped by 5.38%, closing at CA$3.87. This decline is particularly notable given the company's recent announcements of record revenues, which typically would bolster investor confidence. The market's reaction suggests that investors are wary of the company's ability to turn revenue growth into sustainable profitability.
Market Sentiment and Future Outlook
Despite reporting a record annual global medical cannabis net revenue of CA$288.6 million, the negative sentiment surrounding Aurora Cannabis's stock indicates a disconnect between financial performance and market perception. Investors should consider the broader industry challenges and Aurora's ongoing losses, which may affect its future stock performance. For more insights into Aurora Cannabis's financials, visit our stock page.
Investor Considerations
With a market cap of CA$253 million and a profit margin of -0.4241, Aurora Cannabis faces significant hurdles. Investors need to weigh the company's growth potential against the risks associated with its current financial performance. As Aurora continues to expand its operations, including recent acquisitions, the path to profitability remains uncertain. For detailed analysis, check out our Aurora Cannabis stock page.
Advertisement
